← FDA Drug Approvals (Drugs@FDA)
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2024-12-30
Drug application
- FDA Application #
ANDA217288- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Generic name
- Brimonidine Tartrate
- Active ingredients
- BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- AMNEAL
- First approval
- 2024-12-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown